ORCHARD THERAPEUTICS PLC Finite-Lived Intangible Asset, Expected Amortization, after Year Five
ORCHARD THERAPEUTICS PLC had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $1.84 million as of 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2023-03-14
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $1.84M.
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $2.33M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, after Year Five |
|---|---|
| 2022-12-31 | $1.84M 10-K · filed 2023-03-14 |
| 2021-12-31 | $2.33M 10-K · filed 2022-03-30 |